deltatrials
Terminated PHASE1 INTERVENTIONAL NCT00300027

Study of BMS-582664 in Combination With Either FOLFIRI or FOLFOX for Gastrointestinal (GI) Malignancies

A Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of BMS-582664 in Combination With 5-Fluorouracil/Leucovorin and Irinotecan or Oxaliplatin for Patients With Advanced or Metastatic Cancer

Sponsor: Bristol-Myers Squibb

Conditions Gastrointestinal Neoplasms
Interventions BMS-582664
Updated 7 times since 2017 Last updated: Feb 27, 2010 Started: Apr 30, 2006 Primary completion: Dec 31, 2006
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Bristol-Myers Squibb

See all terminations from Bristol-Myers Squibb

Other Gastrointestinal Neoplasms trials with similar outcome

Browse all Gastrointestinal Neoplasms trials

This PHASE1 trial investigates Gastrointestinal Neoplasms and is currently terminated or withdrawn. Bristol-Myers Squibb leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Apr 2022 · 15 months · monthly snapshotTerminated~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  4. Apr 2022 — Jul 2024 [monthly]

    Terminated PHASE1

  5. Jan 2021 — Apr 2022 [monthly]

    Terminated PHASE1

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE1

  2. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE1

    First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bristol-Myers Squibb
Data source: Bristol-Myers Squibb

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations